Novosanis NV Report issue

For profit Phase 1
Founded: Wijnegem Belgium (2013)
Status: Acquired by OraSure Technologies (2019)

Organization Overview

First Clinical Trial
2016
NCT02186977
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Novosanis NV